Armstrong Kathryn Michelle 4

What Happened

• Kathryn Michelle Armstrong, Chief Scientific Officer of USANA Health Sciences (USNA), was granted 24,526 restricted stock units (RSUs) on February 19, 2026. The award is reported as a derivative grant at $0.00 per unit (total reported value $0 at grant). This is an equity award, not an open-market purchase or sale.

Key Details

• Transaction date: February 19, 2026; Form 4 filed February 23, 2026 (within the two-business-day filing window).
• Grant size: 24,526 RSUs; reported acquisition price $0.00 (award).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — each RSU = a contingent right to one share of USNA common stock. F2 — RSUs vest 25% on each February 19 thereafter (i.e., annual pro rata vesting over four years).
• No 10b5-1 plan, tax-withholding sale, or immediate sale reported in this filing.

Context

• RSU grants are compensation awards that convert to actual shares only as they vest; they do not represent immediate stock purchases or sales and should be interpreted as part of executive compensation rather than a direct market sentiment signal.